Texas Attorney General, Ken Paxton, is after pharma once again—invoking a very familiar theory. Last month, in a suit almost identical to the suit filed against Eli Lilly last year, Paxton filed suit against Sanofi-Aventis US LLC (“Sanofi”) in state court for Sanofi’s alleged kickbacks to providers in violation of the Texas Health Care Program Fraud Prevention Act (“THFPA”)….
By: Sheppard, Mullin, Richter & Hampton LLP
By: Sheppard, Mullin, Richter & Hampton LLP
